Evidence map›Paper›PMID 30140944›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2019

Towards a universal MRI atlas of the prostate and prostate zones : Comparison of MRI vendor and image acquisition parameters.

Kyle R Padgett, Amy Swallen, Sara Pirozzi, Jon Piper, Felix M Chinea, Matthew C Abramowitz, Aaron Nelson, Alan Pollack, Radka Stoyanova

Abstract readComparative Study
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The role of radiomics in prostate cancer radiotherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Review
  9. Segmentation of prostate and prostate zones using deep learning : A multi-MRI vendor analysis.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Article
  10. Automatic image segmentation based on synthetic tissue model for delineating organs at risk in spinal metastasis treatment planning.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kyle R PadgettDepartment of Radiology, Miller School of Medicine University of Miami, Miami, FL, USA.
Amy SwallenResearch and Development, MIM software Inc., Cleveland, OH, USA.
Sara PirozziResearch and Development, MIM software Inc., Cleveland, OH, USA.
Jon PiperResearch and Development, MIM software Inc., Cleveland, OH, USA.
Felix M ChineaDepartment of Radiology, Miller School of Medicine University of Miami, Miami, FL, USA.
Matthew C AbramowitzDepartment of Radiology, Miller School of Medicine University of Miami, Miami, FL, USA.
Aaron NelsonResearch and Development, MIM software Inc., Cleveland, OH, USA.
Alan PollackDepartment of Radiology, Miller School of Medicine University of Miami, Miami, FL, USA.
Radka StoyanovaDepartment of Radiation Oncology, Miller School of Medicine University of Miami, 1475 NW 12th Avenue, Suite 1515J, 33136, Miami, FL, USA. rstoyanova@med.miami.edu.

Funding

MRI Imaging and Genetic Signatures to Manage Prostate Cancer OverdiagnosisR01CA189295 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI POLLACK, ALAN · 2014 to 2018
$3.2M
(PQC4) Habitats in Prostate CancerR01CA190105 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI BALAGURUNATHAN, YOGANAND, GILLIES, ROBERT J. · 2014 to 2017
$2.8M
National Cancer Institute R01CA189295National Cancer Institute R01CA190105NCI NIH HHS R01 CA189295NCI NIH HHS R01 CA190105
6 · The paper itself

Abstract

background and purposeThe aim of this study was to evaluate an automatic multi-atlas-based segmentation method for generating prostate, peripheral (PZ), and transition zone (TZ) contours on MRIs with and without fat saturation (±FS), and compare MRIs from different vendor MRI systems.

methodsT2-weighted (T2) and fat-saturated (T2FS) MRIs were acquired on 3T GE (GE, Waukesha, WI, USA) and Siemens (Erlangen, Germany) systems. Manual prostate and PZ contours were used to create atlas libraries. As a test MRI is entered, the procedure for atlas segmentation automatically identifies the atlas subjects that best match the test subject, followed by a normalized intensity-based free-form deformable registration. The contours are transformed to the test subject, and Dice similarity coefficients (DSC) and Hausdorff distances between atlas-generated and manual contours were used to assess performance.

resultsThree atlases were generated based on GE_T2 (n = 30), GE_T2FS (n = 30), and Siem_T2FS (n = 31). When test images matched the contrast and vendor of the atlas, DSCs of 0.81 and 0.83 for T2 ± FS were obtained (baseline performance). Atlases performed with higher accuracy when segmenting (i) T2FS vs. T2 images, likely due to a superior contrast between prostate vs. surrounding tissue; (ii) prostate vs. zonal anatomy; (iii) in the mid-gland vs. base and apex. Atlases performance declined when tested with images with differing contrast and MRI vendor. Conversely, combined atlases showed similar performance to baseline.

conclusionThe MRI atlas-based segmentation method achieved good results for prostate, PZ, and TZ compared to expert contoured volumes. Combined atlases performed similarly to matching atlas and scan type. The technique is fast, fully automatic, and implemented on commercially available clinical platform.

Indexed as

Anatomy, ArtisticAtlases as TopicCommerceHumansImage EnhancementImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleProstateSensitivity and SpecificityMagnetic resonance imagingProstate neoplasmsRadiation oncologistsRadiotherapySegmentation

Identifiers

PMID30140944
PMCPMC6358462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.